Top Markets
#1 Palladium Network Palladium Network +27.91%
#2 Siren Siren +25.01%
#3 BankrCoin BankrCoin +19.86%
#4 Ankr Network Ankr Network +17.93%
#5 Prom Prom +14.29%
#6 ICON ICON +13.06%
#7 Status Status +12.14%
#8 Hive Hive +9.82%
#9 Provenance Blockchain Provenance Blockchain +9.13%
#10 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.84%
Coin of the day
Palladium Network Palladium Network
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Classifica tra le azioni #17830
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Prezzo delle azioni
$5.84
Ultima sincronizzazione: 2025-04-02
Capitalizzazione di mercato
$224.09M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Nevro Corp. (NVRO)

Categoria

Healthcare
Ricavi di Nevro Corp. (NVRO)
Ricavi nel Dec 2024 TTM: $408.52M
Secondo gli ultimi rapporti finanziari di Nevro Corp., i ricavi attuali dell'azienda (TTM) sono pari a $408.52M. Nel 2023, l'azienda ha registrato ricavi di $425.17M un aumento rispetto a i ricavi dell'anno 2022, che erano pari a $406.37M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Nevro Corp. da 2012 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $408.52M 0.00%
2024 $408.52M -3.92%
2023 $425.17M 4.63%
2022 $406.37M 5.03%
2021 $386.91M 6.87%
2020 $362.05M -7.23%
2019 $390.26M 0.77%
2018 $387.29M 18.56%
2017 $326.67M 42.96%
2016 $228.50M 228.28%
2015 $69.61M 113.69%
2014 $32.57M 38.61%
2013 $23.50M 29.48%
2012 $18.15M 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 11,303.41%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 6,224.57%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 8,586.03%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 5,039.55%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B 1,494.13%
US